In a SLEEP 2026 abstract, the authors (which include Jacobowitz) state: The findings suggest that GLP-1 [receptor agonist]s are currently disrupting traditional OSA treatment patterns, and that these medications may expand the total pool of patients seeking treatment for CPAP-alternatives, ultimately increasing the [hypoglossal nerve stimulator]-BMI eligible population. 1 Sequencing Strategies As the toolbox grows, the question for clinicians shifts from if to when and how to introduce options
In this guide, well break down what we know (and what we dont) about BPC-157s half-life, how long it stays in your body, and how this impacts its safe and effective use
A dossier has been submitted for EFSA evaluation
After disinfecting the treatment area, your Vitamin B-12 injection will be administered via a thin needle into your arm, thigh, or buttocks
Oral supplements often dont provide the full benefits due to limited absorption in the digestive tract